BioCentury
ARTICLE | Clinical News

Synthon preclinical data

February 11, 2013 8:00 AM UTC

In mouse xenograft models of epidermal growth factor receptor 2 ( EGFR2; HER2; ErbB2; neu)-positive breast cancer and non-small cell lung cancer (NSCLC), Synthon's anti-HER2-ADC induced complete tu...